Jon Glass, MD

 

NYC Office:
530 First Ave, Suite 9S
New York, NY 10016

jglassmd@neuro-oncology.org

Return to previous page

PA Office:
707 Lakeside Drive
Southampton, PA 18966

Tel: (212) 263-6267
Fax: (212) 263-5715

 

Tel: (215) 518-4195
Fax: (215) 357-7709

BIOGRAPHICAL:

Date of Birth: May 5, 1960
Birthplace: Brooklyn, NY
Marital Status: Married, six children

MEDICAL LICENSURE:

State of New Jersey, 1995
State of New York, 1995
Commonwealth of Pennsylvania, 1992
Commonwealth of Massachusetts: 1988

BOARD CERTIFICATION:

American Board of Psychiatry and Neurology. Certificate 38614

EDUCATION:

9/l/78 to 5/23/82 Brandeis University, Waltham, MA. BA, Biochemistry
9/l/82 to 5/15/86 State University of New York Downstate Medical Center, Brooklyn, NY MD, with Distinction in Research

PROFESSIONAL EXPERIENCE:

7/l/86 to 6/30/87 Kings County Hospital, Brooklyn, NY. Intern, Internal Medicine
7/l/87 to 6/30/90 Boston University Medical Center, Boston, MA. Resident, Neurology
7/l/90 to 6/30/92 Massachusetts General Hospital, Boston, MA. Clinical and Research Fellow, Neuro-oncology
7/l/92 to 6/30/93 Temple University Hospital, Philadelphia, PA. Atternding, Neuology
7/l/92 to12/31/93 Temple University Cancer Center, Philadelphia, PA. Attending and Consultant, Neuro-oncology
7/l/93 to 8/31/95 Crozer-Chester Medical Center, Upland, PA. Attending Staff, Neurology, Department of Medicine
7/l/93 to present Taylor Hospital, Ridley Park, PA. Attending Staff, (Consulting), Dept of Medicine, Div of Neurology
7/l/93 to present Riddle Memorial Hospital, Media, PA. Attending Staff, (Courtesy), Dept of Medicine, Div. of Neurology
1/4/96 to present Tisch Hospital, New York, NY. Attending Staff, Neurology

ACADEMIC APPOINTMENTS:

7/l/87 to 6/30/90 Boston University Medical Center, Boston, MA. Teaching Fellow, Neurology
7/l/90 to 6/30/92 Harvard Medical School, Boston, MA. Research Fellow, Neurology
7/l/92 to 6/30/93 Temple University Hospital, Philadelphia, PA. Assistant Professor, Neurology
1/4/96 to present New York University School of Medicine, New York, NY. Assistant Professor of Neurology

PROFESSIONAL ACTIVITIES (SELECTED):

Ad-Hoc Reviewer: Cancer, Acta Haematologica, Journal of Neuro-oncology
Brain Committee, Radiation Therapy Oncology Group
Member, Society for Neuro-oncology

PUBLICATIONS:

  1. Glass J, Clouet D, Gintzler AR. Short-term nerve stimulation increases enkephalin content and production in the guinea-pig myenteric plexus. Brain Res 372: 180-184, 1986.
  2. Glass J, Chan WC, Gintzler AR. Direct analysis of the release of methionine enkephalin from guinea-pig myenteric plexus: Modulation by endogenous opioids and exogenous morphine. J Pharmacol Exp Therap 239:742-747, 1987.
  3. Gintzler AR, Chan WC, Glass J. Evoked release of methionine enkephalin from tolerant/dependent enteric ganglia: Paradoxical dependence on morphine. Proc Natl Acad Sci USA 84:2537-2539, 1987.
  4. Rosen BR, Belliveau JW, Aronen HJ, Kennedy D, Buchbinder BR, Gruber M, Glass J, Weisskoff RM, Cohen MS, Hochberg FH, Brady TJ. Susceptibility contrast imaging of cerebral blood volume: Human experience. Magn Reson Med 22:293-299, 1991.
  5. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. The treatment of oligodendrogliomas and oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 76:741-745, 1992.
  6. Glass J, Hochberg FH, Miller DC. Intravascular lymphomatosis: A systemic disease with neurological manifestations. Cancer 71:3156-3164, 1993.
  7. Glass J, Gruber ML, Cher L, Hochberg FH. Pre-irradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome. J Neurosurg 81:188-195, 1994.
  8. Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, Gazit IE, Linggood RM, Fischman AJ, Rosen BR, Hochberg FH. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiol 36:520528, 1995.
  9. Andrews DW, Silverman CL, Glass J, Downes B, Riley RJ, Corn BW, Wener-Wasik M, Curran WJ, McCune CE, Rosenwasser RH, Buchheit WA. Preservation of cranial nerve function after treatment of acoustic neurinomas with fractionated stereotactic radiotherapy: Preliminary observations in 26 patients. Stereotact Funct Neurosurg 64:165-182, 1995.
  10. Cher L, Glass J, Harsh GR, Hochberg FH. Therapy of primary central nervous system lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 46:1757-1759, 1996.
  11. Corn BW, Andrews DW, Silverman CL, Rosenwasser RH, Buchheit WA, Glass J. Detailed initial analysis of the treatment of cranial chordoma with fractionated stereotactic irradiation. Radiat Oncol Investig 4:17-22, 1996.
  12. Glass J, Shustik C, Hochberg FH, Cher L, Gruber ML. Therapy Of Primary Central Nervous System Lymphoma with Pre-Irradiation Methotrexate, Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone (MCHOD). J Neuro-oncology 30:257-265, 1996.
  13. Glass J, Silverman CL, Axelrod R, Andrews DW. Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol 20:226-229, 1997.
  14. Bakshi R, Glass J, Louis DN, Hochberg FH. Magnetic resonance imaging features of solitary inflammatory brain masses. Journal of Neuroimaging 8:8-14, 1998.
  15. Horwitz AD, Hosek R, Boyle J, Cianciulli A, Glass J, Codario R. A new gatekeeper for back pain. Am J Man Care 4:576-589, 1998.
  16. Gruber ML, Glass J, Choudhri H, Nirenberg A. Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme. Am J Clin Oncol (CCT) 21:338-340, 1998.
  17. Glass J, Corn BW, Silverman CL, Hoenig E, Andrews DW. Possible early emergence of infield second neoplasms following cranial irradiation, chemotherapy, and stereotactic irradiation. Report of two cases. (In Press, The Journal of Radiosurgery).
  18. Glass J, Gruber ML, Nirenberg A: Phase I/II study of treatment of recurrent glioblastoma multiforme with carboplatin and thalidomide (in preparation).
  19. Mannancheril A, Nirenberg A, Gruber M, Glass J, Kancherla R, Seiter K, Benzil D, Durrani H, Ahmed T. Tandem high dose chemotherapy with thiotepa and carboplatin followed by peripheral blood stem cell support for patients with malignant brain tumors. (In Preparation).

BOOK CHAPTER:

  1. Glass J. Lumbar Puncture. in Macdonald JS, Haller DG, Mayer RJ (eds): Manual of Oncologic Therapeutics, Third Edition. Philadelphia, J. B. Lippincott Company, 33-34, 1995.

REVIEW ARTICLE:

  1. Hochberg FH, Glass J. Review Article: Primary central nervous system lymphoma: Diagnosis and treatment. Neurology Chronicle 1: 1-3, 1991.

SELECTED ABSTRACTS:

  1. Glass J, Clouet D, Gintzler AR. Short-term nerve stimulation increases enkephalin production in the guinea-pig myenteric plexus. International Opiate Research Conference, 1985.
  2. Glass J, Gruber ML, Hochberg FH. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. Ninth International Conference on Brain Tumor Research and Therapy, 1991.
  3. Aronen HJ, Buchbinder BR, Hochberg FH, McKinstry RC, Belliveau JW, Linggood RM, Glass J, Boxerman JL, Neuder MS, Weisskoff RM, Cohen MS, Vevea JM, Kwong KK, Brady TJ, Rosen BR. Comparison of hyperscan diffusion and dynamic susceptibility contrast CBV imaging in human brain tumors. Book of Abstracts, Society of Magnetic Resonance in Medicine, 1991.
  4. Aronen HJ, Belliveau JW, Kennedy, DN, Buchbinder BR, Goldberg IE, Fischman A, Gruber M, Glass J, Brady TJ, Hochberg F, Rosen BR. Functional MRI and PET studies of Primary Human Brain Tumors. Book of Abstracts, Society of Magnetic Resonance in Medicine, 1992.
  5. Glass J, Gruber ML, Hochberg FH. Chemotherapy of primary central nervous system lymphoma (PCNSL) with MCHOD (Methotrexate [MTX], cyclophosphamide, Adriamycin, vincristine, dexamethasone) prior to radiation therapy (RT). Neurology 43:A209,1993.
  6. Andrews DW, Silverman CL, Glass J, Downes B, Xue T, Thomas P, Buchheit WA. Multiple-fraction LINAC-based radiosurgery for the treatment of intracranial and skull-base tumors: Review of 48 cases. The World Society for Stereotactic and Functional Neurosurgery, 1993.
  7. Glass J, Silverman CL, Axelrod R, Andrews DW. Multiple fraction stereotactic radiosurgery (SRS) with cis-platinum (CDDP) radiosensitization in the therapy of malignant glioma. Neurology 44:A310, 1994.
  8. Cher L, Glass J, Hochberg FH. Treatment of primary central nervous system lymphoma (PCNSL) with high-dose methotrexate (HDM7X) and deferred whole brain radiation therapy (WBRT). Neurology 44:A378, 1994.
  9. Choudhri H, Glass J, Nirenberg A, Gruber ML. Pre-irradiation chemotherapy of glioblastoma multiforme with carboplatin. Poster presentation, Joint Section on Tumors, Congress of Neurological Surgeons, October 3, 1996.
  10. Choudhri H, Gruber ML, Nirenberg A, Glass J. High dose neoadjuvant carboplatin chemotherapy in the management of newly diagnosed malignant glioma. Poster presentation, Congress of Neurological Surgeons meeting, October, 1997.
  11. Glass J, Gruber ML, Nirenberg A: Phase I/II study of treatment of recurrent glioblastoma multiforme with carboplatin and thalidomide (Submitted, ASCO 1999).
  12. Mannancheril A, Nirenberg A, Gruber M, Glass J, Kancherla R, Seiter K, Benzil D, Durrani H, Ahmed T. Tandem high dose chemtherapy with thiotepa and carboplatin followed by peripheral blood stem cell support for patients with maligant brain tumors. (Submitted, ASCO 1999).